Facilitators and barriers to in vitro diagnostics implementation in resource-limited settings: A scoping review.
LMICs.
barriers
essential in vitro diagnostics
facilitators
primary healthcare facilities
Journal
African journal of primary health care & family medicine
ISSN: 2071-2936
Titre abrégé: Afr J Prim Health Care Fam Med
Pays: South Africa
ID NLM: 101520860
Informations de publication
Date de publication:
03 Feb 2023
03 Feb 2023
Historique:
received:
08
08
2022
accepted:
08
11
2022
revised:
30
10
2022
entrez:
2
3
2023
pubmed:
3
3
2023
medline:
4
3
2023
Statut:
epublish
Résumé
The World Health Organization (WHO) developed the model list of essential in vitro diagnostics (EDL) to guide countries to develop and update point-of-care (POC) per their disease priorities. The EDL includes POC diagnostic tests for use in health facilities without laboratories; however, their implementation might face several challenges in low- and middle-income countries (LMICs). To identify facilitators and barriers to POC testing service implementations in the primary health care facilities in the LMICs. Low- and middle-income countries. This scoping review was guided by Arksey and O'Malley's methodological framework. A comprehensive keyword search for literature was conducted in Google Scholar, EBSCOhost, PubMed, Web of Science and ScienceDirect using the Boolean terms ('AND' and 'OR'), as well as Medical Subject Headings. The study considered published articles in the English language from 2016 to 2021 and was limited to qualitative, quantitative and mixed-method studies. Two reviewers independently screened the articles at the abstract and full-text screening phases guided by the eligibility criteria. Data were analysed qualitatively and quantitatively. Of the 57 studies identified through literature searches, 16 met this study's eligibility criteria. Of the 16 studies, 7 reported on both facilitators and barriers; and the remainder reported on only barriers to POC test implementation such as inadequate funding, insufficient human resource, stigmatisation, et cetera. The study demonstrated a wide research gap in facilitators and barriers, especially in the general POC diagnostic test for use in health facilities without laboratories in the LMICs. Extensive research in POC testing service is recommended to improve service delivery.Contribution: This study's findings contribute to a few works of literature on existing evidence of POC testing.
Sections du résumé
BACKGROUND
BACKGROUND
The World Health Organization (WHO) developed the model list of essential in vitro diagnostics (EDL) to guide countries to develop and update point-of-care (POC) per their disease priorities. The EDL includes POC diagnostic tests for use in health facilities without laboratories; however, their implementation might face several challenges in low- and middle-income countries (LMICs).
AIM
OBJECTIVE
To identify facilitators and barriers to POC testing service implementations in the primary health care facilities in the LMICs.
SETTING
METHODS
Low- and middle-income countries.
METHODS
METHODS
This scoping review was guided by Arksey and O'Malley's methodological framework. A comprehensive keyword search for literature was conducted in Google Scholar, EBSCOhost, PubMed, Web of Science and ScienceDirect using the Boolean terms ('AND' and 'OR'), as well as Medical Subject Headings. The study considered published articles in the English language from 2016 to 2021 and was limited to qualitative, quantitative and mixed-method studies. Two reviewers independently screened the articles at the abstract and full-text screening phases guided by the eligibility criteria. Data were analysed qualitatively and quantitatively.
RESULTS
RESULTS
Of the 57 studies identified through literature searches, 16 met this study's eligibility criteria. Of the 16 studies, 7 reported on both facilitators and barriers; and the remainder reported on only barriers to POC test implementation such as inadequate funding, insufficient human resource, stigmatisation, et cetera.
CONCLUSION
CONCLUSIONS
The study demonstrated a wide research gap in facilitators and barriers, especially in the general POC diagnostic test for use in health facilities without laboratories in the LMICs. Extensive research in POC testing service is recommended to improve service delivery.Contribution: This study's findings contribute to a few works of literature on existing evidence of POC testing.
Identifiants
pubmed: 36861922
doi: 10.4102/phcfm.v15i1.3777
pmc: PMC9982514
doi:
Types de publication
Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1-e9Références
Diagnostics (Basel). 2021 Dec 08;11(12):
pubmed: 34943536
PLoS One. 2019 Feb 14;14(2):e0212035
pubmed: 30763378
Prog Community Health Partnersh. 2020;14(3):327-335
pubmed: 33416608
PLoS One. 2017 Jul 27;12(7):e0182005
pubmed: 28750083
Curr Opin Biomed Eng. 2019 Sep;11:9-15
pubmed: 32864521
Pilot Feasibility Stud. 2019 Jan 25;5:18
pubmed: 30701079
Diagnostics (Basel). 2020 Apr 01;10(4):
pubmed: 32244633
Clin Med (Lond). 2019 Mar;19(2):145-148
pubmed: 30872299
Diagnostics (Basel). 2017 Nov 29;7(4):
pubmed: 29186013
Diagnostics (Basel). 2019 Oct 18;9(4):
pubmed: 31635219
Point Care. 2019 Mar;18(1):17-25
pubmed: 30886544
Glob Health Innov. 2019;2(2):1-5
pubmed: 34278295
BMJ Open. 2018 Oct 24;8(10):e023925
pubmed: 30361406
Lancet Glob Health. 2019 Oct;7(10):e1295-e1296
pubmed: 31537347
Diagnostics (Basel). 2021 Jul 13;11(7):
pubmed: 34359335
Anal Chim Acta. 2021 Feb 15;1146:184-199
pubmed: 33461715
Heliyon. 2019 Feb 19;5(2):e01236
pubmed: 30828664
Blood Cells Mol Dis. 2017 Sep;67:104-113
pubmed: 28844459
BMJ Open. 2019 Nov 25;9(11):e029260
pubmed: 31772084
BMJ Open. 2021 Apr 13;11(4):e042944
pubmed: 33849848
Sensors (Basel). 2019 Apr 23;19(8):
pubmed: 31018573
Biotechnol J. 2018 Jan;13(1):
pubmed: 29178532
BMC Infect Dis. 2017 Nov 1;17(Suppl 1):702
pubmed: 29143612
PLoS One. 2020 Oct 15;15(10):e0240476
pubmed: 33057444
BMC Health Serv Res. 2019 Jan 28;19(1):74
pubmed: 30691447
BMC Fam Pract. 2016 Nov 3;17(1):149
pubmed: 27809865
Indian J Community Med. 2016 Jan-Mar;41(1):1-4
pubmed: 26917865
PLoS One. 2019 Feb 27;14(2):e0211498
pubmed: 30811407
PLoS One. 2019 Nov 22;14(11):e0225642
pubmed: 31756242
EBioMedicine. 2021 Jan;63:103181
pubmed: 33421948
Virulence. 2019 Dec;10(1):1034-1046
pubmed: 31775570
Ann Intern Med. 2018 Oct 2;169(7):467-473
pubmed: 30178033
Malar J. 2019 Nov 11;18(1):360
pubmed: 31711489
BMC Health Serv Res. 2017 May 30;17(1):378
pubmed: 28558812
South Afr J HIV Med. 2020 Jul 22;21(1):1105
pubmed: 32832116
BMC Health Serv Res. 2020 May 19;20(1):444
pubmed: 32429903
Ups J Med Sci. 2015 Mar;120(1):1-10
pubmed: 25622619
BMJ Open. 2020 Nov 19;10(11):e043679
pubmed: 33444219
AIDS Res Hum Retroviruses. 2020 Jul;36(7):550-555
pubmed: 32070109
J Hand Surg Am. 2021 Jul;46(7):602-607
pubmed: 33832787
BMJ Open. 2020 Jan 15;10(1):e033428
pubmed: 31948989
J Int AIDS Soc. 2019 Jul;22 Suppl 3:e25293
pubmed: 31321884
BMC Health Serv Res. 2018 Feb 20;18(1):130
pubmed: 29458363
Diagnostics (Basel). 2017 Jan 08;7(1):
pubmed: 28075337
BMC Health Serv Res. 2019 Jul 24;19(1):519
pubmed: 31340833
Implement Sci Commun. 2021 Aug 11;2(1):89
pubmed: 34380567
RSC Adv. 2018 Oct 3;8(59):34012-34034
pubmed: 35548839
BMC Health Serv Res. 2022 Feb 10;22(1):171
pubmed: 35144602
Chem Rev. 2019 Jan 23;119(2):1456-1518
pubmed: 30511833
BMC Health Serv Res. 2015 Oct 05;15:454
pubmed: 26438342
Diagnostics (Basel). 2020 Feb 01;10(2):
pubmed: 32024166
Sex Transm Infect. 2017 Dec;93(S4):S59-S64
pubmed: 29223964